Calcium citrate and Tagrisso drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Calcium citrate (calcium) and Tagrisso (osimertinib mesylate). Common drug interactions include c-reactive protein increased among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Calcium citrate and Tagrisso. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Calcium citrate?

Calcium citrate has active ingredients of calcium. It is often used in osteopenia. eHealthMe is studying from 12,606 Calcium citrate users. Check the latest studies of Calcium citrate.

What is Tagrisso?

Tagrisso has active ingredients of osimertinib mesylate. eHealthMe is studying from 19,890 Tagrisso users. Check the latest studies of Tagrisso.

On Jul, 13, 2026

18 people who take Calcium citrate and Tagrisso together, and have interactions are studied.

Calcium citrate and Tagrisso drug interactions.

What are the common drug interactions of Calcium Citrate and Tagrisso, by gender? *:

female:

C-reactive protein increased
Inflammation
Malignant neoplasm progression (cancer tumour came back)
Rash
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Abdominal pain upper
Death
Decreased appetite
Dysgeusia (disorder of the sense of taste)

male:

Fatigue (feeling of tiredness)
Pneumonia
Anaemia (lack of blood)
Cough
Dyspnoea (difficult or laboured respiration)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Lung adenocarcinoma (a form of non-small cell lung cancer)
Muscle disorder (muscle disease)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)

What are the common drug interactions of Calcium Citrate and Tagrisso, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Acute respiratory distress syndrome
Anaemia (lack of blood)
Cough
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Lung adenocarcinoma (a form of non-small cell lung cancer)
Muscle disorder (muscle disease)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)

What are the existing conditions these people have? *

Lung Neoplasm Malignant (cancer tumour of lung): 8 people, 44.44%
Lung Cancer - Non-Small Cell (lung cancer): 5 people, 27.78%
Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 11.11%
Lung Carcinoma Cell Type Unspecified Stage 0 (the lung cancer has not spread beyond the inner lining of the lung): 2 people, 11.11%
Lung Cancer Metastatic (lung cancer spreads to other parts): 2 people, 11.11%
Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 2 people, 11.11%
Tumor: 2 people, 11.11%
Cough: 1 person, 5.56%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.56%
Brain Neoplasm Malignant (brain cancer tumour): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Calcium citrate and Tagrisso?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously